A $15.8 billion dollar bidding war for Salix Pharmaceuticals just came to a dramatic end as Valeant Pharmaceuticals beat Endo International with an all-cash offer for the company. While some sectors would view this as game changing, the pharmaceutical industry is beginning to see this as status quo.…